ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,949, issued on April 15, was assigned to PeriphaGen Inc. (Pittsburgh).
"High-transducing HSV vectors" was invented by David M. Krisky (Pittsburgh), James B. Wechuck (Pittsburgh) and James R. Goss (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain."
The patent was filed on July 26, 2023, under Application No. 18/359,013.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&...